SCHEMBL6258629

SCHEMBL6258629

C[C@@H](O)C(Oc1ccc2sc(C3CCCCC3)nc2c1)N1CCN(CCn2cc(-c3ccc(F)cc3)cn2)CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.40
LIPC P11150 3/20 0.36
SPR P35270 1/20 0.34
MAPT P10636 4/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 3/20 0.33
THRB P10828 1/20 0.33
S1PR1 P21453 1/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
MET P08581 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
PLK1 P53350 1/20 0.32
LIPG Q9Y5X9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256837 0.93 MAPT (0.37) LMNALIPCMAPTSMN1; SMN2TP53
SCHEMBL6258490 0.88 CYP1A2 (0.42) LIPCCYP3A4CYP2C9
SCHEMBL6613291 0.88 CYP1A2 (0.42) LIPCCYP3A4CYP2C9
SCHEMBL5901488 0.86 CYP1A2 (0.42) CYP3A4CYP2C9
SCHEMBL5965124 0.86 CYP1A2 (0.42) CYP3A4CYP2C9
SCHEMBL6261209 0.85 DRD2 (0.37) LIPCS1PR1GSK3BDYRK1AMET
SCHEMBL6615762 0.85 CYP3A4 (0.38) LIPCTSHRSMN1; SMN2TP53S1PR1
SCHEMBL6617750 0.82 LMNA (0.36) LMNALIPCSPRMAPTTSHR
SCHEMBL6185941 0.82 LMNA (0.37) LMNALIPCSPRMAPTTSHR
SCHEMBL6259851 0.80 CYP3A4 (0.39) LIPCTSHRSMN1; SMN2TP53S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583760-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV Therapeutics Inc. (US) 2005-10-12 EP disclosed
WO-2004067506-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS INC. (US) 2004-08-12 WO disclosed